{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T16:28:35Z","timestamp":1788452915015,"version":"build-2803163510"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,1,26]],"date-time":"2021-01-26T00:00:00Z","timestamp":1611619200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,1,26]],"date-time":"2021-01-26T00:00:00Z","timestamp":1611619200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No.81873799"],"award-info":[{"award-number":["No.81873799"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Hemorrhagic transformation (HT) is a serious neurological complication of acute ischemic stroke (AIS) after revascularization. The majority of AIS patients do not have atrial fibrillation (AF) which could also develop into HT. In this study, we aimed to explore whether hemostasis parameters are risk factors of HT in non-AF patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We consecutively enrolled 285 AIS patients with HT. Meanwhile, age- and sex-matched 285 AIS patients without HT were included. The diagnosis of HT was determined by brain CT or MRI during hospitalization. All patients were divided into two subgroups based on the presence of AF and explore the differences between the two subgroups. Blood samples were obtained within 24\u2009h of admission, and all patients were evenly classified into three tertiles according to platelet counts (PLT) levels.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      In this study, we found the first PLT tertile (OR = 3.509, 95%CI = 1.268\u20139.711,\n                      <jats:italic>P<\/jats:italic>\n                      = 0.016) was independently associated with HT in non-AF patients, taking the third tertile as a reference. Meanwhile, we also found mean platelet volume (MPV) (OR = 0.605, 95%CI = 0.455\u20130.805,\n                      <jats:italic>P<\/jats:italic>\n                      = 0.001) and fibrinogen (FIB) (OR = 1.928, 95%CI = 1.346\u20132.760,\n                      <jats:italic>P<\/jats:italic>\n                      &lt;\u20090.001) were significantly associated with HT in non-AF patients. But in AF patients, hemostasis parameters showed no significant difference. Meanwhile, we found the MPV (OR = 1.314, 95%CI = 1.032\u20131.675,\n                      <jats:italic>P<\/jats:italic>\n                      = 0.027) and FIB (OR = 1.298, 95%CI = 1.047\u20131.610,\n                      <jats:italic>P<\/jats:italic>\n                      = 0.018) were significantly associated with long-term outcomes in non-AF HT patients.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Low PLT, low MPV, and high FIB levels were independently associated with HT in non-AF patients. Additionally, MPV and FIB levels were significantly associated with unfavorable long-term outcomes in non-AF HT patients. Our study showed that hemostasis functions at admission may be beneficial for clinicians to recognize patients with a high risk of HT at an early stage and improve unfavorable long-term outcomes in non-AF patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12883-021-02065-3","type":"journal-article","created":{"date-parts":[[2021,1,26]],"date-time":"2021-01-26T01:02:54Z","timestamp":1611622974000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Hemostasis functions are associated with hemorrhagic transformation in non-atrial fibrillation patients: a case-control study"],"prefix":"10.1186","volume":"21","author":[{"given":"Hao-Ran","family":"Cheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun-Bin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-Ying","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Ting","family":"Ruan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-Xiang","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian-Qian","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Jun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Qian","family":"Luan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gui-Qian","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5493-4357","authenticated-orcid":false,"given":"Jin-Cai","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,26]]},"reference":[{"key":"2065_CR1","doi-asserted-by":"crossref","first-page":"175628641987326","DOI":"10.1177\/1756286419873264","volume":"12","author":"J Li","year":"2019","unstructured":"Li J, Zhang P, Wu S, Wang Y, Zhou J, Yi X, Wang C. Stroke-related complications in large hemisphere infarction: incidence and influence on unfavorable outcome. Ther Adv Neurol Disord. 2019;12:1756286419873264.","journal-title":"Ther Adv Neurol Disord"},{"issue":"1","key":"2065_CR2","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1161\/STROKEAHA.111.623033","volume":"43","author":"C Gumbinger","year":"2012","unstructured":"Gumbinger C, Gruschka P, Bottinger M, Heerlein K, Barrows R, Hacke W, Ringleb P. Improved prediction of poor outcome after thrombolysis using conservative definitions of symptomatic hemorrhage. Stroke. 2012;43(1):240\u20132.","journal-title":"Stroke"},{"issue":"3","key":"2065_CR3","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1111\/ene.13859","volume":"26","author":"A Guenego","year":"2019","unstructured":"Guenego A, Lecler A, Raymond J, Sabben C, Khoury N, Premat K, Botta D, Boisseau W, Maier B, Ciccio G, et al. Hemorrhagic transformation after stroke: inter- and intrarater agreement. Eur J Neurol. 2019;26(3):476\u201382.","journal-title":"Eur J Neurol"},{"issue":"9","key":"2065_CR4","doi-asserted-by":"publisher","first-page":"2728","DOI":"10.1161\/STROKEAHA.114.005135","volume":"45","author":"NM Rao","year":"2014","unstructured":"Rao NM, Levine SR, Gornbein JA, Saver JL. Defining clinically relevant cerebral hemorrhage after thrombolytic therapy for stroke: analysis of the National Institute of Neurological Disorders and Stroke tissue-type plasminogen activator trials. Stroke. 2014;45(9):2728\u201333.","journal-title":"Stroke"},{"issue":"5\u20136","key":"2065_CR5","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1159\/000460265","volume":"43","author":"J Kaesmacher","year":"2017","unstructured":"Kaesmacher J, Kaesmacher M, Maegerlein C, Zimmer C, Gersing AS, Wunderlich S, Friedrich B, Boeckh-Behrens T, Kleine JF. Hemorrhagic Transformations after Thrombectomy: Risk Factors and Clinical Relevance. Cerebrovasc Dis (Basel, Switzerland). 2017;43(5\u20136):294\u2013304.","journal-title":"Cerebrovasc Dis (Basel, Switzerland)"},{"issue":"8","key":"2065_CR6","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.1016\/j.jstrokecerebrovasdis.2019.04.034","volume":"28","author":"BS Demirtas","year":"2019","unstructured":"Demirtas BS, Ocek L, Zorlu Y, Oztekin O. Factors associated with hemorrhagic transformation in infarctions involving the posterior circulation system. J Stroke Cerebrovasc Dis. 2019;28(8):2193\u2013200.","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"12","key":"2065_CR7","doi-asserted-by":"publisher","first-page":"3587","DOI":"10.1016\/j.jstrokecerebrovasdis.2018.08.028","volume":"27","author":"WQ Ge","year":"2018","unstructured":"Ge WQ, Chen J, Pan H, Chen F, Zhou CY. Analysis of risk factors increased hemorrhagic transformation after acute ischemic stroke. J Stroke Cerebrovasc Dis. 2018;27(12):3587\u201390.","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"2065_CR8","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.clineuro.2019.04.018","volume":"181","author":"Y Jiao","year":"2019","unstructured":"Jiao Y, Li G, Xing Y, Nie D, Liu X. Influencing factors of hemorrhagic transformation in non-thrombolysis patients with cerebral infarction. Clin Neurol Neurosurg. 2019;181:68\u201372.","journal-title":"Clin Neurol Neurosurg"},{"issue":"12","key":"2065_CR9","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1111\/ene.13747","volume":"25","author":"G Zhang","year":"2018","unstructured":"Zhang G, He M, Xu Y, Li X, Cai Z, Guo Z, Meng P, Ji N, He X, Pang L. Hemoglobin A1c predicts hemorrhagic transformation and poor outcomes after acute anterior stroke. Eur J Neurol. 2018;25(12):1432\u2013e1122.","journal-title":"Eur J Neurol"},{"issue":"3","key":"2065_CR10","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.jjcc.2014.07.021","volume":"65","author":"Y Nakano","year":"2015","unstructured":"Nakano Y, Kondo T, Osanai H, Murase Y, Nakashima Y, Asano H, Ajioka M, Sakai K, Inden Y, Murohara T. Clinical usefulness of measuring prothrombin time and soluble fibrin levels in Japanese patients with atrial fibrillation receiving rivaroxaban. J Cardiol. 2015;65(3):185\u201390.","journal-title":"J Cardiol"},{"issue":"6","key":"2065_CR11","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1007\/s40520-017-0733-8","volume":"29","author":"TN Nguyen","year":"2017","unstructured":"Nguyen TN, Morel-Kopp MC, Pepperell D, Cumming RG, Hilmer SN, Ward CM. The impact of frailty on coagulation and responses to warfarin in acute older hospitalised patients with atrial fibrillation: a pilot study. Aging Clin Exp Res. 2017;29(6):1129\u201338.","journal-title":"Aging Clin Exp Res"},{"issue":"4","key":"2065_CR12","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1111\/ijs.12007","volume":"10","author":"HT Tu","year":"2015","unstructured":"Tu HT, Campbell BC, Christensen S, Desmond PM, De Silva DA, Parsons MW, Churilov L, Lansberg MG, Mlynash M, Olivot JM, et al. Worse stroke outcome in atrial fibrillation is explained by more severe hypoperfusion, infarct growth, and hemorrhagic transformation. Int J Stroke. 2015;10(4):534\u201340.","journal-title":"Int J Stroke"},{"issue":"10","key":"2065_CR13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0026087","volume":"6","author":"W Pfeilschifter","year":"2011","unstructured":"Pfeilschifter W, Spitzer D, Pfeilschifter J, Steinmetz H, Foerch C. Warfarin anticoagulation exacerbates the risk of hemorrhagic transformation after rt-PA treatment in experimental stroke: therapeutic potential of PCC. PLoS One. 2011;6(10):e26087.","journal-title":"PLoS One"},{"issue":"8","key":"2065_CR14","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1161\/STROKEAHA.118.022856","volume":"50","author":"R Altavilla","year":"2019","unstructured":"Altavilla R, Caso V, Bandini F, Agnelli G, Tsivgoulis G, Yaghi S, Furie KL, Tadi P, Becattini C, Zedde M, et al. Anticoagulation after stroke in patients with atrial fibrillation. Stroke. 2019;50(8):2093\u2013100.","journal-title":"Stroke"},{"issue":"8","key":"2065_CR15","doi-asserted-by":"publisher","first-page":"1886","DOI":"10.1161\/STROKEAHA.118.021228","volume":"49","author":"KW Nam","year":"2018","unstructured":"Nam KW, Kim TJ, Lee JS, Kwon HM, Lee YS, Ko SB, Yoon BW. High neutrophil-to-lymphocyte ratio predicts stroke-associated pneumonia. Stroke. 2018;49(8):1886\u201392.","journal-title":"Stroke"},{"issue":"3","key":"2065_CR16","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1161\/STROKEAHA.116.015900","volume":"48","author":"C Lang","year":"2017","unstructured":"Lang C, Seyfang L, Ferrari J, Gattringer T, Greisenegger S, Willeit K, Toell T, Krebs S, Brainin M, Kiechl S, et al. Do women with atrial fibrillation experience more severe strokes? Results from the Austrian stroke unit registry. Stroke. 2017;48(3):778\u201380.","journal-title":"Stroke"},{"issue":"3","key":"2065_CR17","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1136\/heartjnl-2018-313351","volume":"105","author":"C Christersson","year":"2019","unstructured":"Christersson C, Wallentin L, Andersson U, Alexander JH, Alings M, De Caterina R, Gersh BJ, Granger CB, Halvorsen S, Hanna M, et al. Effect of apixaban compared with warfarin on coagulation markers in atrial fibrillation. Heart. 2019;105(3):235\u201342.","journal-title":"Heart"},{"issue":"5","key":"2065_CR18","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1111\/jth.14001","volume":"16","author":"S Testa","year":"2018","unstructured":"Testa S, Paoletti O, Legnani C, Dellanoce C, Antonucci E, Cosmi B, Pengo V, Poli D, Morandini R, Testa R, et al. Low drug levels and thrombotic complications in high-risk atrial fibrillation patients treated with direct oral anticoagulants. J Thromb Haemost : JTH. 2018;16(5):842\u20138.","journal-title":"J Thromb Haemost : JTH"},{"issue":"8","key":"2065_CR19","doi-asserted-by":"publisher","first-page":"2249","DOI":"10.1161\/STROKEAHA.107.510321","volume":"39","author":"M Paciaroni","year":"2008","unstructured":"Paciaroni M, Agnelli G, Corea F, Ageno W, Alberti A, Lanari A, Caso V, Micheli S, Bertolani L, Venti M, et al. Early hemorrhagic transformation of brain infarction: rate, predictive factors, and influence on clinical outcome: results of a prospective multicenter study. Stroke. 2008;39(8):2249\u201356.","journal-title":"Stroke"},{"issue":"9136","key":"2065_CR20","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1016\/S0140-6736(98)08020-9","volume":"352","author":"W Hacke","year":"1998","unstructured":"Hacke W, Kaste M, Fieschi C, von Kummer R, Davalos A, Meier D, Larrue V, Bluhmki E, Davis S, Donnan G, et al. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators. Lancet (London, England). 1998;352(9136):1245\u201351.","journal-title":"Lancet (London, England)"},{"issue":"4","key":"2065_CR21","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1161\/STROKEAHA.117.020031","volume":"49","author":"R Ornello","year":"2018","unstructured":"Ornello R, Degan D, Tiseo C, Di Carmine C, Perciballi L, Pistoia F, Carolei A, Sacco S. Distribution and temporal trends from 1993 to 2015 of ischemic stroke subtypes: a systematic review and meta-analysis. Stroke. 2018;49(4):814\u20139.","journal-title":"Stroke"},{"issue":"2","key":"2065_CR22","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1159\/000079260","volume":"18","author":"H Adams","year":"2004","unstructured":"Adams H, Leclerc J, Bluhmki E, Clarke W, Hansen M, Hacke W. Measuring outcomes as a function of baseline severity of ischemic stroke. Cerebrovasc Dis (Basel, Switzerland). 2004;18(2):124\u20139.","journal-title":"Cerebrovasc Dis (Basel, Switzerland)"},{"issue":"9","key":"2065_CR23","doi-asserted-by":"publisher","first-page":"1984","DOI":"10.1161\/01.STR.0000177872.87960.61","volume":"36","author":"M Uyttenboogaart","year":"2005","unstructured":"Uyttenboogaart M, Stewart RE, Vroomen PC, De Keyser J, Luijckx GJ. Optimizing cutoff scores for the Barthel index and the modified Rankin scale for defining outcome in acute stroke trials. Stroke. 2005;36(9):1984\u20137.","journal-title":"Stroke"},{"issue":"6","key":"2065_CR24","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1111\/j.1755-5949.2012.00312.x","volume":"18","author":"N Zhang","year":"2012","unstructured":"Zhang N, Wang C, Wang A, Bai Y, Zhou Y, Wang Y, Zhang T, Zhou J, Yu X, Sun X, et al. Time course of depression and one-year prognosis of patients with stroke in mainland China. CNS Neurosci Ther. 2012;18(6):475\u201381.","journal-title":"CNS Neurosci Ther"},{"issue":"2","key":"2065_CR25","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1161\/STROKEAHA.111.635276","volume":"43","author":"J Putaala","year":"2012","unstructured":"Putaala J, Haapaniemi E, Kaste M, Tatlisumak T. How does number of risk factors affect prognosis in young patients with ischemic stroke? Stroke. 2012;43(2):356\u201361.","journal-title":"Stroke"},{"issue":"2","key":"2065_CR26","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1136\/jnnp-2016-314817","volume":"89","author":"P Kelly","year":"2018","unstructured":"Kelly P, Murphy S, Coveney S, Purroy F, Lemmens R, Tsivgoulis G, Price C. Anti-inflammatory approaches to ischaemic stroke prevention. J Neurol Neurosurg Psychiatry. 2018;89(2):211\u20138.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"7","key":"2065_CR27","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1590\/0004-282x20200008","volume":"78","author":"J Andrade","year":"2020","unstructured":"Andrade J, Mohr J, Lima F, Barros L, Nepomuceno C, Portela L, Silva G. Predictors of hemorrhagic transformation after acute ischemic stroke based on the experts' opinion. Arq Neuropsiquiatr. 2020;78(7):390\u20136.","journal-title":"Arq Neuropsiquiatr"},{"issue":"14","key":"2065_CR28","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.4103\/0366-6999.235873","volume":"131","author":"MS Liu","year":"2018","unstructured":"Liu MS, Liao Y, Li GQ. Glomerular filtration rate is associated with hemorrhagic transformation in acute ischemic stroke patients without thrombolytic therapy. Chin Med J. 2018;131(14):1639\u201344.","journal-title":"Chin Med J"},{"issue":"5","key":"2065_CR29","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1007\/s00415-014-7297-8","volume":"261","author":"S Tan","year":"2014","unstructured":"Tan S, Wang D, Liu M, Zhang S, Wu B, Liu B. Frequency and predictors of spontaneous hemorrhagic transformation in ischemic stroke and its association with prognosis. J Neurol. 2014;261(5):905\u201312.","journal-title":"J Neurol"},{"issue":"1","key":"2065_CR30","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.jstrokecerebrovasdis.2018.09.047","volume":"28","author":"GK Vilanilam","year":"2019","unstructured":"Vilanilam GK, Badi MK, Yarlagadda B, Okromelidze L. Hemorrhagic transformation after acute ischemic stroke in atrial fibrillation patients. J Stroke Cerebrovasc Dis. 2019;28(1):234.","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"3","key":"2065_CR31","doi-asserted-by":"publisher","first-page":"e46","DOI":"10.1161\/STR.0000000000000158","volume":"49","author":"WJ Powers","year":"2018","unstructured":"Powers WJ, Rabinstein AA, Ackerson T, Adeoye OM, Bambakidis NC, Becker K, Biller J, Brown M, Demaerschalk BM, Hoh B, et al. 2018 guidelines for the early Management of Patients with Acute Ischemic Stroke: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association. Stroke. 2018;49(3):e46\u2013e110.","journal-title":"Stroke"},{"issue":"5","key":"2065_CR32","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1093\/qjmed\/hcy292","volume":"112","author":"R Wang","year":"2019","unstructured":"Wang R, Zeng J, Wang F, Zhuang X, Chen X, Miao J. Risk factors of hemorrhagic transformation after intravenous thrombolysis with rt-PA in acute cerebral infarction. QJM. 2019;112(5):323\u20136.","journal-title":"QJM"},{"issue":"6","key":"2065_CR33","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1111\/j.1538-7836.2010.03851.x","volume":"8","author":"CI Prodan","year":"2010","unstructured":"Prodan CI, Stoner JA, Cowan LD, Dale GL. Lower coated-platelet levels are associated with early hemorrhagic transformation in patients with non-lacunar brain infarction. J Thromb Haemost : JTH. 2010;8(6):1185\u201390.","journal-title":"J Thromb Haemost : JTH"},{"key":"2065_CR34","doi-asserted-by":"crossref","unstructured":"Ho-Tin-No\u00e9 B, Demers M, Wagner D. How platelets safeguard vascular integrity. J Thromb Haemost : JTH. 2011:56\u201365.","DOI":"10.1111\/j.1538-7836.2011.04317.x"},{"issue":"1","key":"2065_CR35","doi-asserted-by":"publisher","first-page":"8309","DOI":"10.1038\/s41598-019-44845-5","volume":"9","author":"A Salas-Perdomo","year":"2019","unstructured":"Salas-Perdomo A, Miro-Mur F, Gallizioli M. Role of the S1P pathway and inhibition by fingolimod in preventing hemorrhagic transformation after stroke. Sci Rep. 2019;9(1):8309.","journal-title":"Sci Rep"},{"issue":"5","key":"2065_CR36","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/0049-3848(83)90255-4","volume":"32","author":"JF Martin","year":"1983","unstructured":"Martin JF, Trowbridge EA, Salmon G, Plumb J. The biological significance of platelet volume: its relationship to bleeding time, platelet thromboxane B2 production and megakaryocyte nuclear DNA concentration. Thromb Res. 1983;32(5):443\u201360.","journal-title":"Thromb Res"},{"issue":"10","key":"2065_CR37","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1111\/j.1742-1241.2009.02070.x","volume":"63","author":"L Vizioli","year":"2009","unstructured":"Vizioli L, Muscari S, Muscari A. The relationship of mean platelet volume with the risk and prognosis of cardiovascular diseases. Int J Clin Pract. 2009;63(10):1509\u201315.","journal-title":"Int J Clin Pract"},{"issue":"2","key":"2065_CR38","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1097\/00001721-199603000-00011","volume":"7","author":"PM Bath","year":"1996","unstructured":"Bath PM, Butterworth RJ. Platelet size: measurement, physiology and vascular disease. Blood Coagul Fibrinolysis. 1996;7(2):157\u201361.","journal-title":"Blood Coagul Fibrinolysis"},{"key":"2065_CR39","doi-asserted-by":"publisher","first-page":"493","DOI":"10.2147\/CIA.S195451","volume":"14","author":"J Staszewski","year":"2019","unstructured":"Staszewski J, Pogoda A, Data K, Walczak K, Nowocien M, Frankowska E, Stepien A. The mean platelet volume on admission predicts unfavorable stroke outcomes in patients treated with IV thrombolysis. Clin Interv Aging. 2019;14:493\u2013503.","journal-title":"Clin Interv Aging"},{"key":"2065_CR40","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.wneu.2017.01.091","volume":"101","author":"X Xu","year":"2017","unstructured":"Xu X, Li C, Wan T, Gu X, Zhu W, Hao J, Bao H, Zuo L, Hu H, Li G. Risk factors for hemorrhagic transformation after intravenous thrombolysis in acute cerebral infarction: a retrospective single-center study. World neurosurg. 2017;101:155\u201360.","journal-title":"World neurosurg"},{"issue":"16","key":"2065_CR41","doi-asserted-by":"publisher","first-page":"6385","DOI":"10.18632\/aging.102195","volume":"11","author":"GQ Huang","year":"2019","unstructured":"Huang GQ, Zeng YY, Cheng QQ, Cheng HR, Ruan YT, Yuan CX, Chen YB, He WL, Chen HJ, He JC. Low triiodothyronine syndrome is associated with hemorrhagic transformation in patients with acute ischaemic stroke. Aging. 2019;11(16):6385\u201397.","journal-title":"Aging"},{"issue":"7","key":"2065_CR42","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/S1474-4422(13)70055-3","volume":"12","author":"J Alvarez-Sabin","year":"2013","unstructured":"Alvarez-Sabin J, Maisterra O, Santamarina E, Kase CS. Factors influencing haemorrhagic transformation in ischaemic stroke. Lancet Neurol. 2013;12(7):689\u2013705.","journal-title":"Lancet Neurol"},{"issue":"6","key":"2065_CR43","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1182\/blood-2018-07-818211","volume":"133","author":"JP Luyendyk","year":"2019","unstructured":"Luyendyk JP, Schoenecker JG, Flick MJ. The multifaceted role of fibrinogen in tissue injury and inflammation. Blood. 2019;133(6):511\u201320.","journal-title":"Blood"},{"key":"2065_CR44","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.brainres.2014.07.004","volume":"1578","author":"A Ito","year":"2014","unstructured":"Ito A, Niizuma K, Shimizu H, Fujimura M, Hasumi K, Tominaga T. SMTP-7, a new thrombolytic agent, decreases hemorrhagic transformation after transient middle cerebral artery occlusion under warfarin anticoagulation in mice. Brain Res. 2014;1578:38\u201348.","journal-title":"Brain Res"},{"issue":"4","key":"2065_CR45","doi-asserted-by":"publisher","DOI":"10.3171\/2012.1.FOCUS11366","volume":"32","author":"R Babu","year":"2012","unstructured":"Babu R, Bagley JH, Di C, Friedman AH, Adamson C. Thrombin and hemin as central factors in the mechanisms of intracerebral hemorrhage-induced secondary brain injury and as potential targets for intervention. Neurosurg Focus. 2012;32(4):E8.","journal-title":"Neurosurg Focus"},{"issue":"12","key":"2065_CR46","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1089\/neu.2019.6582","volume":"37","author":"H Krenzlin","year":"2020","unstructured":"Krenzlin H, Gresser E, Jussen D, Riede N, Taylor L, Vogelaar CF, Ringel F, Kempski O, Alessandri B. The Cerebral Thrombin System Is Activated after Intracerebral Hemorrhage and Contributes to Secondary Lesion Growth and Poor Neurological Outcome in C57Bl\/6 Mice. J Neurotrauma. 2020;37(12):1481\u201390.","journal-title":"J Neurotrauma"},{"issue":"22","key":"2065_CR47","doi-asserted-by":"publisher","first-page":"7622","DOI":"10.1523\/JNEUROSCI.0369-12.2012","volume":"32","author":"B Chen","year":"2012","unstructured":"Chen B, Friedman B, Whitney MA, Winkle JA, Lei IF, Olson ES, Cheng Q, Pereira B, Zhao L, Tsien RY, Lyden PD. Thrombin activity associated with neuronal damage during acute focal ischemia. J Neurosci. 2012;32(22):7622\u201331.","journal-title":"J Neurosci"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-021-02065-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12883-021-02065-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-021-02065-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,26]],"date-time":"2021-01-26T01:03:38Z","timestamp":1611623018000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-021-02065-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,26]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2065"],"URL":"https:\/\/doi.org\/10.1186\/s12883-021-02065-3","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-104422\/v1","asserted-by":"object"}]},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,26]]},"assertion":[{"value":"10 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Institutional Review Board (IRB), the First Affiliated Hospital of Wenzhou Medical University, and was following the Declaration of Helsinki promulgated by the National Institute of Health. We didn\u2019t have informed consent for it was a retrospective study and the patient profile was anonymous. The acquisition of retrospective data was approved by the Ethics Committee of the First Affiliated Hospital of Wenzhou Medical University and the Neurology Department of the First Affiliated Hospital of Wenzhou Medical University.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not Applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"36"}}